Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C097949 |
1,25-dihydroxyvitamin D |
1,25-dihydroxyvitamin D inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL5 protein] | decreases reaction|increases secretion | 16367934
|
C038983 |
1,3-dimethylthiourea |
1,3-dimethylthiourea inhibits the reaction [Reactive Oxygen Species results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 10495789
|
C038983 |
1,3-dimethylthiourea |
1,3-dimethylthiourea inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 10495789
|
C038983 |
1,3-dimethylthiourea |
1,3-dimethylthiourea results in decreased expression of CCL5 mRNA | decreases expression | 11128050
|
C004482 |
1-aminopyrene |
1-aminopyrene results in increased expression of CCL5 mRNA | increases expression | 19879285
|
C032668 |
1-nitropyrene |
1-nitropyrene results in increased expression of CCL5 mRNA | increases expression | 19879285
|
C005975 |
3,4-dihydroxyphenylethanol |
[Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in decreased expression of CCL5 mRNA | affects cotreatment|decreases expression | 16797527
|
C046693 |
3-aminofluoranthene |
3-aminofluoranthene results in increased expression of CCL5 mRNA | increases expression | 19879285
|
C486633 |
4'-hydroxy-3'-methoxyacetophenone |
4'-hydroxy-3'-methoxyacetophenone inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 10495789
|
C501474 |
4-OH-2',3,3',4',5'-pentachlorobiphenyl |
4-OH-2',3,3',4',5'-pentachlorobiphenyl inhibits the reaction [Triiodothyronine results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 14761676
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of CCL5 mRNA | affects expression | 17562736
|
D000082 |
Acetaminophen |
Acetaminophen results in increased expression of CCL5 mRNA | increases expression | 15578514
|
D000082 |
Acetaminophen |
Acetaminophen inhibits the reaction [Vitamin K 3 results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 19265712
|
D000082 |
Acetaminophen |
Acetaminophen inhibits the reaction [Vitamin K 3 results in increased secretion of CCL5 protein] | decreases reaction|increases secretion | 19265712
|
D000111 |
Acetylcysteine |
Acetylcysteine inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 10495789
|
D000171 |
Acrolein |
Acrolein results in increased expression of CCL5 mRNA | increases expression | 17950725
|
D000171 |
Acrolein |
CD8A protein promotes the reaction [Acrolein results in increased expression of CCL5 mRNA] | increases expression|increases reaction | 17950725
|
D000420 |
Albuterol |
[Beclomethasone co-treated with Albuterol] results in decreased secretion of CCL5 protein | affects cotreatment|decreases secretion | 15679717
|
D006710 |
Homocysteine |
[Homocysteine co-treated with Lipopolysaccharides] results in increased secretion of CCL5 protein | affects cotreatment|increases secretion | 16225753
|
D006710 |
Homocysteine |
Homocysteine results in increased expression of CCL5 mRNA | increases expression | 16225753
|
D015081 |
2-Naphthylamine |
2-Naphthylamine results in increased expression of CCL5 mRNA | increases expression | 18247414
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CCL5 mRNA | affects expression | 16483693
|
C416282 |
BAY 11-7085 |
BAY 11-7085 inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of CCL5 protein] | decreases reaction|increases expression | 17015710
|
D001507 |
Beclomethasone |
[Beclomethasone co-treated with Albuterol] results in decreased secretion of CCL5 protein | affects cotreatment|decreases secretion | 15679717
|
D001507 |
Beclomethasone |
[Beclomethasone co-treated with formoterol] results in decreased secretion of CCL5 protein | affects cotreatment|decreases secretion | 15679717
|
D001554 |
Benzene |
Benzene results in increased expression of CCL5 protein | increases expression | 11306435
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene promotes the reaction [AHR protein results in increased expression of CCL5 protein] | increases expression|increases reaction | 12200463
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of CCL5 mRNA | increases expression | 18247414
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of CCL5 protein | increases expression | 11306435
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of CCL5 mRNA | decreases expression | 20713471
|
C004532 |
benzoquinone |
benzoquinone results in increased expression of CCL5 protein | increases expression | 17572062
|
C020711 |
beryllium sulfate |
beryllium sulfate results in increased expression of CCL5 mRNA | increases expression | 16314022
|
D015124 |
8-Bromo Cyclic Adenosine Monophosphate |
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Reactive Oxygen Species results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 10495789
|
D015124 |
8-Bromo Cyclic Adenosine Monophosphate |
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 10495789
|
D002084 |
Butylated Hydroxytoluene |
Butylated Hydroxytoluene results in decreased expression of CCL5 mRNA | decreases expression | 19925653
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of CCL5 mRNA | increases expression | 14729362 15003993
|
C055494 |
caffeic acid phenethyl ester |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CCL5 mRNA | affects cotreatment|decreases expression | 20360939
|
D000001 |
Calcimycin |
CCL5 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species] | affects abundance|affects chemical synthesis|increases reaction | 12797483
|
D000001 |
Calcimycin |
IL5 protein promotes the reaction [CCL5 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]] | affects abundance|affects chemical synthesis|increases reaction | 12797483
|
D000001 |
Calcimycin |
[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4 | affects cotreatment|increases secretion | 18083043
|
D000001 |
Calcimycin |
CCL5 protein promotes the reaction [Calcimycin results in increased expression of ALOX5 mRNA] | increases expression|increases reaction | 18083043
|
D000001 |
Calcimycin |
CCL5 protein promotes the reaction [Calcimycin results in increased expression of ALOX5 protein] | increases expression|increases reaction | 18083043
|
D000001 |
Calcimycin |
Dexamethasone inhibits the reaction [[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4] | affects cotreatment|decreases reaction|increases secretion | 18083043
|
D000001 |
Calcimycin |
Dexamethasone inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein] | affects cotreatment|decreases reaction|increases expression | 18083043
|
D000001 |
Calcimycin |
Nordihydroguaiaretic Acid inhibits the reaction [[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4] | affects cotreatment|decreases reaction|increases secretion | 18083043
|
D000001 |
Calcimycin |
Nordihydroguaiaretic Acid inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 mRNA] | affects cotreatment|decreases reaction|increases expression | 18083043
|
D000001 |
Calcimycin |
Nordihydroguaiaretic Acid inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein] | affects cotreatment|decreases reaction|increases expression | 18083043
|
D002118 |
Calcium |
CCL5 protein results in increased uptake of Calcium | increases uptake | 10984371
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of CCL5 protein | increases expression | 17412915
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of CCL5 mRNA | affects expression | 15963342
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in decreased expression of CCL5 mRNA | decreases expression | 16239168
|
D002351 |
Carrageenan |
Carrageenan results in increased expression of CCL5 protein | increases expression | 12444156
|
D002351 |
Carrageenan |
isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein] | decreases reaction|increases expression | 14654164
|
D002351 |
Carrageenan |
Quercetin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein] | decreases reaction|increases expression | 14654164
|
C034221 |
catechol |
catechol results in increased expression of CCL5 protein | increases expression | 17572062
|
C099555 |
CD 437 |
CD 437 results in decreased expression of CCL5 mRNA | decreases expression | 12958071
|
C105934 |
celecoxib |
celecoxib results in decreased expression of CCL5 mRNA | decreases expression | 12902868
|
C039671 |
ciglitazone |
ciglitazone inhibits the reaction [Thioglycolates results in increased secretion of CCL5 protein] | decreases reaction|increases secretion | 12624547
|
C433247 |
Cilomilast |
Cilomilast inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of CCL5 protein] | decreases reaction|increases expression | 15491423
|
C055162 |
clopidogrel |
clopidogrel results in increased expression of CCL5 mRNA | increases expression | 16856976
|
D003907 |
Dexamethasone |
Dexamethasone inhibits the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CCL5 protein] | affects binding|decreases reaction|increases expression | 16908450
|
D003907 |
Dexamethasone |
Dexamethasone inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 10495789
|
D003907 |
Dexamethasone |
Dexamethasone inhibits the reaction [TNF protein results in increased expression of CCL5 protein] | decreases reaction|increases expression | 10495789
|
D003907 |
Dexamethasone |
Dexamethasone inhibits the reaction [[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4] | affects cotreatment|decreases reaction|increases secretion | 18083043
|
D003907 |
Dexamethasone |
Dexamethasone inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein] | affects cotreatment|decreases reaction|increases expression | 18083043
|
D002945 |
Cisplatin |
Cisplatin results in increased expression of CCL5 mRNA | increases expression | 15814532
|
D002945 |
Cisplatin |
Cisplatin results in increased expression of CCL5 protein | increases expression | 15814532
|
D002945 |
Cisplatin |
pirinixic acid inhibits the reaction [Cisplatin results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 15814532
|
D002945 |
Cisplatin |
pirinixic acid inhibits the reaction [Cisplatin results in increased expression of CCL5 protein] | decreases reaction|increases expression | 15814532
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of CCL5 mRNA | increases expression | 18457598
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CCL5 mRNA | affects cotreatment|decreases expression | 20360939
|
C014477 |
diflorasone diacetate |
diflorasone diacetate inhibits the reaction [Dinitrochlorobenzene results in increased expression of CCL5 protein] | decreases reaction|increases expression | 15491423
|
C014477 |
diflorasone diacetate |
diflorasone diacetate inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of CCL5 protein] | decreases reaction|increases expression | 15491423
|
D015127 |
9,10-Dimethyl-1,2-benzanthracene |
9,10-Dimethyl-1,2-benzanthracene promotes the reaction [AHR protein results in increased expression of CCL5 mRNA] | increases expression|increases reaction | 12200463
|
D004137 |
Dinitrochlorobenzene |
diflorasone diacetate inhibits the reaction [Dinitrochlorobenzene results in increased expression of CCL5 protein] | decreases reaction|increases expression | 15491423
|
D004137 |
Dinitrochlorobenzene |
Dinitrochlorobenzene results in increased expression of CCL5 protein | increases expression | 15491423
|
D004139 |
Dinitrofluorobenzene |
Dinitrofluorobenzene results in increased expression of CCL5 mRNA | increases expression | 15719370
|
D004139 |
Dinitrofluorobenzene |
Dinitrofluorobenzene results in increased expression of CCL5 protein | increases expression | 15719370
|
D004391 |
Dust |
Dust results in decreased expression of CCL5 protein | decreases expression | 17805423
|
D004391 |
Dust |
Dust results in increased expression of CCL5 mRNA | increases expression | 17805423
|
D004958 |
Estradiol |
[Estradiol co-treated with norethindrone acetate] results in decreased expression of CCL5 protein | affects cotreatment|decreases expression | 16842799
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in decreased expression of CCL5 mRNA | affects cotreatment|decreases expression | 17404688
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of CCL5 mRNA | decreases expression | 12538720
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of CCL5 mRNA | increases expression | 15885639
|
C007650 |
ethyl acetate |
ethyl acetate results in increased expression of CCL5 protein | increases expression | 11306435
|
C093230 |
fexofenadine |
fexofenadine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 15460210
|
C093230 |
fexofenadine |
fexofenadine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 protein] | decreases reaction|increases expression | 15460210
|
C093230 |
fexofenadine |
fexofenadine inhibits the reaction [TNF protein results in increased expression of CCL5 protein] | decreases reaction|increases expression | 15460210
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of CCL5 mRNA | decreases expression | 18035473
|
C012629 |
formoterol |
[Beclomethasone co-treated with formoterol] results in decreased secretion of CCL5 protein | affects cotreatment|decreases secretion | 15679717
|
D005576 |
Forskolin |
Forskolin inhibits the reaction [Reactive Oxygen Species results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 10495789
|
D005576 |
Forskolin |
Forskolin inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 10495789
|
D005620 |
Freund's Adjuvant |
[Urethane co-treated with Freund's Adjuvant] results in increased expression of CCL5 mRNA | affects cotreatment|increases expression | 12400877
|
C007789 |
fucoidan |
fucoidan results in decreased expression of CCL5 protein | decreases expression | 16201850
|
C043055 |
gallium arsenide |
gallium arsenide results in increased expression of CCL5 mRNA | increases expression | 14560044
|
D007975 |
Leukotriene B4 |
[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4 | affects cotreatment|increases secretion | 18083043
|
D007975 |
Leukotriene B4 |
Dexamethasone inhibits the reaction [[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4] | affects cotreatment|decreases reaction|increases secretion | 18083043
|
D007975 |
Leukotriene B4 |
Nordihydroguaiaretic Acid inhibits the reaction [[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4] | affects cotreatment|decreases reaction|increases secretion | 18083043
|
D006586 |
Hexanes |
Hexanes results in increased expression of CCL5 protein | increases expression | 11306435
|
D006820 |
Hyaluronic Acid |
Hyaluronic Acid analog results in increased secretion of CCL5 protein | increases secretion | 9278343
|
C031927 |
hydroquinone |
hydroquinone results in increased expression of CCL5 protein | increases expression | 17572062
|
C013038 |
hydroxyhydroquinone |
hydroxyhydroquinone affects the expression of CCL5 protein | affects expression | 17572062
|
D015759 |
Ionomycin |
[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL5 protein | affects cotreatment|increases expression | 17572062
|
D007501 |
Iron |
Iron deficiency results in increased expression of CCL5 mRNA | increases expression | 20368581
|
C016527 |
isoquercitrin |
isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein] | decreases reaction|increases expression | 14654164
|
C006552 |
kaempferol |
[Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in decreased expression of CCL5 mRNA | affects cotreatment|decreases expression | 16797527
|
D008070 |
Lipopolysaccharides |
1,25-dihydroxyvitamin D inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL5 protein] | decreases reaction|increases secretion | 16367934
|
D008070 |
Lipopolysaccharides |
fexofenadine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 15460210
|
D008070 |
Lipopolysaccharides |
fexofenadine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 protein] | decreases reaction|increases expression | 15460210
|
D008070 |
Lipopolysaccharides |
[Homocysteine co-treated with Lipopolysaccharides] results in increased secretion of CCL5 protein | affects cotreatment|increases secretion | 16225753
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides promotes the reaction [Shiga Toxin 2 results in increased secretion of CCL5 protein] | increases reaction|increases secretion | 16366002
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of CCL5 mRNA | increases expression | 15460210
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of CCL5 protein | increases expression | 18684396 15460210
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased secretion of CCL5 protein | increases secretion | 16367934
|
D008070 |
Lipopolysaccharides |
IL6 protein affects the reaction [Lipopolysaccharides results in increased secretion of CCL5 protein] | affects reaction|increases secretion | 15804595
|
D008070 |
Lipopolysaccharides |
[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CCL5 protein | affects cotreatment|increases expression | 15135318
|
D008070 |
Lipopolysaccharides |
mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CCL5 protein] | affects cotreatment|decreases reaction|increases expression | 15135318
|
C013592 |
mangiferin |
mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CCL5 protein] | affects cotreatment|decreases reaction|increases expression | 15135318
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in decreased expression of CCL5 mRNA | decreases expression | 20713471
|
D008770 |
Methylnitrosourea |
Methylnitrosourea results in increased expression of CCL5 mRNA | increases expression | 15240709
|
D009151 |
Mustard Gas |
Mustard Gas results in increased expression of CCL5 protein | increases expression | 17620002
|
D009151 |
Mustard Gas |
Mustard Gas results in increased expression of CCL5 mRNA | increases expression | 18988085
|
D009173 |
Mycophenolic Acid |
Mycophenolic Acid results in decreased expression of CCL5 mRNA | decreases expression | 10688038
|
D009173 |
Mycophenolic Acid |
[Quercetin co-treated with Mycophenolic Acid] results in decreased expression of CCL5 mRNA | affects cotreatment|decreases expression | 10688038
|
D009538 |
Nicotine |
Nicotine results in increased expression of CCL5 mRNA | increases expression | 18247414
|
D009569 |
Nitric Oxide |
Nitric Oxide results in decreased secretion of CCL5 protein | decreases secretion | 13678430
|
D020030 |
Nitric Oxide Donors |
Nitric Oxide Donors results in decreased secretion of CCL5 protein | decreases secretion | 13678430
|
D026422 |
S-Nitrosoglutathione |
S-Nitrosoglutathione results in decreased secretion of CCL5 protein | decreases secretion | 13678430
|
D009637 |
Nordihydroguaiaretic Acid |
Nordihydroguaiaretic Acid inhibits the reaction [[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4] | affects cotreatment|decreases reaction|increases secretion | 18083043
|
D009637 |
Nordihydroguaiaretic Acid |
Nordihydroguaiaretic Acid inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 mRNA] | affects cotreatment|decreases reaction|increases expression | 18083043
|
D009637 |
Nordihydroguaiaretic Acid |
Nordihydroguaiaretic Acid inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein] | affects cotreatment|decreases reaction|increases expression | 18083043
|
C024262 |
norethindrone acetate |
[Estradiol co-treated with norethindrone acetate] results in decreased expression of CCL5 protein | affects cotreatment|decreases expression | 16842799
|
D010126 |
Ozone |
Ozone results in decreased expression of CCL5 mRNA | decreases expression | 12763052
|
D010743 |
Phospholipids |
CCL2 protein promotes the reaction [Phospholipids results in increased expression of CCL5 mRNA] | increases expression|increases reaction | 11937571
|
D010743 |
Phospholipids |
Phospholipids results in increased expression of CCL5 mRNA | increases expression | 11937571
|
C060836 |
pioglitazone |
pioglitazone inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of CCL5 protein] | decreases reaction|increases expression | 17015710
|
C006253 |
pirinixic acid |
pirinixic acid inhibits the reaction [Cisplatin results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 15814532
|
C006253 |
pirinixic acid |
pirinixic acid inhibits the reaction [Cisplatin results in increased expression of CCL5 protein] | decreases reaction|increases expression | 15814532
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of CCL5 mRNA | decreases expression | 17426115
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of CCL5 mRNA | decreases expression | 12832660
|
D011078 |
Polychlorinated Biphenyls |
Polychlorinated Biphenyls inhibits the reaction [Triiodothyronine results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 14761676
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in decreased expression of CCL5 mRNA | affects cotreatment|decreases expression | 17404688
|
D015232 |
Dinoprostone |
Dinoprostone results in decreased expression of CCL5 mRNA | decreases expression | 16303787
|
D015232 |
Dinoprostone |
Dinoprostone inhibits the reaction [Reactive Oxygen Species results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 10495789
|
D015232 |
Dinoprostone |
Dinoprostone inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 10495789
|
C020972 |
pyrrolidine dithiocarbamic acid |
pyrrolidine dithiocarbamic acid inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 10495789
|
D011794 |
Quercetin |
[Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in decreased expression of CCL5 mRNA | affects cotreatment|decreases expression | 16797527
|
D011794 |
Quercetin |
Quercetin results in increased expression of CCL5 mRNA | increases expression | 16455785
|
D011794 |
Quercetin |
[Quercetin co-treated with Mycophenolic Acid] results in decreased expression of CCL5 mRNA | affects cotreatment|decreases expression | 10688038
|
D011794 |
Quercetin |
Quercetin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein] | decreases reaction|increases expression | 14654164
|
D011794 |
Quercetin |
Quercetin results in decreased expression of CCL5 mRNA | decreases expression | 10688038
|
D020849 |
Raloxifene |
Raloxifene results in decreased expression of CCL5 protein | decreases expression | 16842799
|
D017382 |
Reactive Oxygen Species |
CCL5 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species] | affects abundance|affects chemical synthesis|increases reaction | 12797483
|
D017382 |
Reactive Oxygen Species |
IL5 protein promotes the reaction [CCL5 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]] | affects abundance|affects chemical synthesis|increases reaction | 12797483
|
D017382 |
Reactive Oxygen Species |
1,3-dimethylthiourea inhibits the reaction [Reactive Oxygen Species results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 10495789
|
D017382 |
Reactive Oxygen Species |
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Reactive Oxygen Species results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 10495789
|
D017382 |
Reactive Oxygen Species |
Dinoprostone inhibits the reaction [Reactive Oxygen Species results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 10495789
|
D017382 |
Reactive Oxygen Species |
Forskolin inhibits the reaction [Reactive Oxygen Species results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 10495789
|
D017382 |
Reactive Oxygen Species |
Reactive Oxygen Species results in increased expression of CCL5 mRNA | increases expression | 10495789
|
D017382 |
Reactive Oxygen Species |
tetramethylthiourea inhibits the reaction [Reactive Oxygen Species results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 10495789
|
C059514 |
resveratrol |
resveratrol analog results in decreased expression of CCL5 mRNA | decreases expression | 15652768
|
C059514 |
resveratrol |
resveratrol results in decreased expression of CCL5 protein | decreases expression | 17872969
|
D015474 |
Isotretinoin |
Isotretinoin inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 15972972
|
D015474 |
Isotretinoin |
Isotretinoin inhibits the reaction [TNF protein results in increased secretion of CCL5 protein] | decreases reaction|increases secretion | 15972972
|
D015474 |
Isotretinoin |
Isotretinoin results in decreased expression of CCL5 mRNA | decreases expression | 15972972
|
D015474 |
Isotretinoin |
Isotretinoin results in decreased expression of CCL5 mRNA | decreases expression | 15972972
|
C089730 |
rosiglitazone |
rosiglitazone inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of CCL5 protein] | decreases reaction|increases expression | 17015710
|
C093642 |
SB 203580 |
SB 203580 inhibits the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CCL5 protein] | affects binding|decreases reaction|increases expression | 16908450
|
D017632 |
Asbestos, Serpentine |
Asbestos, Serpentine results in increased expression of CCL5 protein | increases expression | 17200189
|
D017632 |
Asbestos, Serpentine |
PRKDC affects the reaction [Asbestos, Serpentine results in increased expression of CCL5 protein] | affects reaction|increases expression | 17200189
|
D022641 |
Shiga Toxin 2 |
Lipopolysaccharides promotes the reaction [Shiga Toxin 2 results in increased secretion of CCL5 protein] | increases reaction|increases secretion | 16366002
|
D022641 |
Shiga Toxin 2 |
Shiga Toxin 2 results in increased secretion of CCL5 protein | increases secretion | 16366002
|
D013467 |
Sulindac |
Sulindac inhibits the reaction [IL1B protein results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 16159934
|
D013467 |
Sulindac |
Sulindac inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 16159934
|
D014284 |
Triiodothyronine |
4-OH-2',3,3',4',5'-pentachlorobiphenyl inhibits the reaction [Triiodothyronine results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 14761676
|
D014284 |
Triiodothyronine |
Polychlorinated Biphenyls inhibits the reaction [Triiodothyronine results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 14761676
|
D014284 |
Triiodothyronine |
Tetrachlorodibenzodioxin promotes the reaction [Triiodothyronine results in increased expression of CCL5 mRNA] | increases expression|increases reaction | 14761676
|
D014284 |
Triiodothyronine |
Triiodothyronine results in increased expression of CCL5 mRNA | increases expression | 14761676
|
D013619 |
Tacrine |
Tacrine results in decreased expression of CCL5 mRNA | decreases expression | 12832660
|
D016559 |
Tacrolimus |
Tacrolimus results in decreased expression of CCL5 mRNA | decreases expression | 15948978
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin promotes the reaction [[AHR protein binds to CCL5 enhancer] which results in increased expression of CCL5 mRNA] | affects binding|increases expression|increases reaction | 12200463
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin promotes the reaction [AHR protein results in increased expression of CCL5 mRNA] | increases expression|increases reaction | 12200463
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin promotes the reaction [AHR protein results in increased expression of CCL5 protein] | increases expression|increases reaction | 12200463
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin promotes the reaction [Triiodothyronine results in increased expression of CCL5 mRNA] | increases expression|increases reaction | 14761676
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of CCL5 mRNA | increases expression | 12200463
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of CCL5 mRNA | decreases expression | 18684927
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of CCL5 mRNA | decreases expression | 20059583
|
D013755 |
Tetradecanoylphorbol Acetate |
[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL5 protein | affects cotreatment|increases expression | 17572062
|
C019107 |
tetramethylthiourea |
tetramethylthiourea inhibits the reaction [Reactive Oxygen Species results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 10495789
|
C019107 |
tetramethylthiourea |
tetramethylthiourea inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 10495789
|
C019107 |
tetramethylthiourea |
tetramethylthiourea results in decreased expression of CCL5 mRNA | decreases expression | 11128050
|
D013864 |
Thioglycolates |
ciglitazone inhibits the reaction [Thioglycolates results in increased secretion of CCL5 protein] | decreases reaction|increases secretion | 12624547
|
D013864 |
Thioglycolates |
Thioglycolates results in increased secretion of CCL5 protein | increases secretion | 12624547
|
D014051 |
Toluene 2,4-Diisocyanate |
CCL5 gene polymorphism affects the susceptibility to Toluene 2,4-Diisocyanate | affects response to substance | 18447907
|
D014051 |
Toluene 2,4-Diisocyanate |
Dexamethasone inhibits the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CCL5 protein] | affects binding|decreases reaction|increases expression | 16908450
|
D014051 |
Toluene 2,4-Diisocyanate |
EGFR protein affects the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CCL5 protein] | affects binding|affects reaction|increases expression | 16908450
|
D014051 |
Toluene 2,4-Diisocyanate |
SB 203580 inhibits the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CCL5 protein] | affects binding|decreases reaction|increases expression | 16908450
|
D014051 |
Toluene 2,4-Diisocyanate |
[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CCL5 protein | affects binding|increases expression | 16908450
|
D014051 |
Toluene 2,4-Diisocyanate |
BAY 11-7085 inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of CCL5 protein] | decreases reaction|increases expression | 17015710
|
D014051 |
Toluene 2,4-Diisocyanate |
Cilomilast inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of CCL5 protein] | decreases reaction|increases expression | 15491423
|
D014051 |
Toluene 2,4-Diisocyanate |
diflorasone diacetate inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of CCL5 protein] | decreases reaction|increases expression | 15491423
|
D014051 |
Toluene 2,4-Diisocyanate |
pioglitazone inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of CCL5 protein] | decreases reaction|increases expression | 17015710
|
D014051 |
Toluene 2,4-Diisocyanate |
PPARG protein affects the reaction [Toluene 2,4-Diisocyanate results in increased expression of CCL5 protein] | affects reaction|increases expression | 17015710
|
D014051 |
Toluene 2,4-Diisocyanate |
rosiglitazone inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of CCL5 protein] | decreases reaction|increases expression | 17015710
|
D014051 |
Toluene 2,4-Diisocyanate |
TNF protein affects the reaction [Toluene 2,4-Diisocyanate results in increased expression of CCL5 mRNA] | affects reaction|increases expression | 12356572
|
D014051 |
Toluene 2,4-Diisocyanate |
Toluene 2,4-Diisocyanate results in increased expression of CCL5 mRNA | increases expression | 11467998 12356572
|
D014051 |
Toluene 2,4-Diisocyanate |
Toluene 2,4-Diisocyanate results in increased expression of CCL5 protein | increases expression | 15491423 17015710
|
D014051 |
Toluene 2,4-Diisocyanate |
Toluene 2,4-Diisocyanate results in increased expression of CCL5 mRNA | increases expression | 15823807
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of CCL5 protein | decreases expression | 17118196
|
D014520 |
Urethane |
[Urethane co-treated with Freund's Adjuvant] results in increased expression of CCL5 mRNA | affects cotreatment|increases expression | 12400877
|
C034028 |
vanadyl sulfate |
vanadyl sulfate results in increased expression of CCL5 protein | increases expression | 18684396
|
D001335 |
Vehicle Emissions |
Vehicle Emissions results in increased expression of CCL5 protein | increases expression | 11306435
|
C025643 |
vinclozolin |
vinclozolin affects the expression of CCL5 mRNA | affects expression | 19015723
|
D014810 |
Vitamin E |
[Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in decreased expression of CCL5 mRNA | affects cotreatment|decreases expression | 16797527
|
D024483 |
Vitamin K 3 |
Acetaminophen inhibits the reaction [Vitamin K 3 results in increased expression of CCL5 mRNA] | decreases reaction|increases expression | 19265712
|
D024483 |
Vitamin K 3 |
Acetaminophen inhibits the reaction [Vitamin K 3 results in increased secretion of CCL5 protein] | decreases reaction|increases secretion | 19265712
|
D024483 |
Vitamin K 3 |
Vitamin K 3 results in increased expression of CCL5 mRNA | increases expression | 19265712
|
D024483 |
Vitamin K 3 |
Vitamin K 3 results in increased secretion of CCL5 protein | increases secretion | 19265712
|
C020174 |
WR 1065 |
WR 1065 results in increased expression of CCL5 mRNA | increases expression | 12007958
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Sulindac |
4.57 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Isotretinoin |
5.73 | 18769834 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
5.73 | 14514962 15322242 11752688 |
MESH:D000015 |
Abnormalities, Multiple |
|
Isotretinoin |
4.15 | 18769834 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
2.66 | 18287403 |
MESH:D017486 |
Acneiform Eruptions |
|
Isotretinoin |
5.36 | 16232082 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
8.93 | 17505938 |
MESH:D000152 |
Acne Vulgaris |
|
Isotretinoin |
8.93 | 18769834 16185265 |
MESH:D054058 |
Acute Coronary Syndrome |
|
clopidogrel |
5.09 | 19106084 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
9.82 | 12690470 15814532 17670903 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
9.82 | 16538975 |
MESH:D058186 |
Acute Kidney Injury |
|
Sulindac |
9.82 | 7897758 |
MESH:D055371 |
Acute Lung Injury |
|
Acrolein |
10.50 | 20525806 21297076 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
10.50 | 11850527 18653653 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
10.50 | 18653653 |
MESH:D000210 |
Acute-Phase Reaction |
|
Thioglycolates |
5.44 | 9464241 |
MESH:D000230 |
Adenocarcinoma |
|
9,10-Dimethyl-1,2-benzanthracene |
18.46 | 12844480 10697514 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
18.46 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
18.46 | 11798837 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
18.46 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
18.46 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Methylnitrosourea |
18.46 | 15113128 15688392 |
MESH:D000230 |
Adenocarcinoma |
|
Sulindac |
18.46 | 11910360 |
MESH:D000230 |
Adenocarcinoma |
|
Urethane |
18.46 | 18316556 |
MESH:D002282 |
Adenocarcinoma, Bronchiolo-Alveolar |
|
Urethane |
4.78 | 15814487 |
MESH:D000236 |
Adenoma |
|
9,10-Dimethyl-1,2-benzanthracene |
22.30 | 11376689 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
22.30 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
22.30 | 10737359 6695378 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
22.30 | 10545420 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
22.30 | 15688382 |
MESH:D000236 |
Adenoma |
|
Sulindac |
22.30 | 10223192 |
MESH:D000236 |
Adenoma |
|
Urethane |
22.30 | 16926031 6695378 17195641 10822126 10530776 11497255 17093202 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
12.06 | 18056438 16434500 17162532 19061943 17620307 19052882 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
12.06 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
12.06 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
celecoxib |
16.55 | 19003578 16215675 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Dinoprostone |
16.55 | 17942926 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Leukotriene B4 |
16.55 | 17942926 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Sulindac |
16.55 | 11874996 19003578 11535846 12394442 17611924 16460482 15623613 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
3.72 | 17308373 17451421 |
OMIM:607154 |
ALLERGIC RHINITIS |
|
fexofenadine |
4.91 | 16037679 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
2.86 | 15955085 |
MESH:D019896 |
alpha 1-Antitrypsin Deficiency |
|
Iron |
4.74 | 16640825 |
MESH:D000544 |
Alzheimer Disease |
|
Acrolein |
20.17 | 17570602 15207723 14715435 |
MESH:D000544 |
Alzheimer Disease |
|
Iron |
20.17 | 16563566 16640825 |
MESH:D000544 |
Alzheimer Disease |
|
Nicotine |
20.17 | 16627626 |
MESH:D000544 |
Alzheimer Disease |
|
Nitric Oxide |
20.17 | 17556102 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
20.17 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
20.17 | 15800139 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
20.17 | 16183991 16162502 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
20.17 | 19621015 |
MESH:D000544 |
Alzheimer Disease |
|
Tacrine |
20.17 | 12725862 |
MESH:D000707 |
Anaphylaxis |
|
mangiferin |
4.58 | 16536907 14669257 |
MESH:D000740 |
Anemia |
|
Iron |
6.24 | 16566752 16434484 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
6.24 | 11748828 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
3.62 | 17661222 14761424 11369114 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
3.41 | 17084956 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Iron |
3.84 | 17147795 16569441 17375513 17162259 17163184 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Iron |
3.98 | 16910769 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
2.92 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
2.89 | 19015723 |
MESH:D001014 |
Aortic Aneurysm |
|
Dinoprostone |
4.73 | 10231640 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
9.03 | 19183758 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Dinoprostone |
9.03 | 10388637 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Iron |
3.57 | 16604332 |
MESH:D001161 |
Arteriosclerosis |
|
Acrolein |
12.01 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
12.01 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
12.01 | 11256880 |
MESH:D001168 |
Arthritis |
|
Leukotriene B4 |
5.26 | 11006272 |
MESH:D001169 |
Arthritis, Experimental |
|
Carrageenan |
16.27 | 17392412 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
16.27 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
16.27 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
16.27 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
16.27 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
3.57 | 15570426 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
3.57 | 16292516 |
MESH:D001195 |
Asbestosis |
|
Asbestos, Serpentine |
4.80 | 10751356 |
MESH:D001249 |
Asthma |
|
Albuterol |
23.32 | 9949315 11991558 |
MESH:D001249 |
Asthma |
|
Beclomethasone |
23.32 | 12114351 8762487 |
MESH:D001249 |
Asthma |
|
Cilomilast |
23.32 | 16956605 |
MESH:D001249 |
Asthma |
|
formoterol |
23.32 | 10967152 12113382 |
MESH:D001249 |
Asthma |
|
Leukotriene B4 |
23.32 | 19667530 11006272 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
23.32 | 10378619 |
MESH:D001249 |
Asthma |
|
Ozone |
23.32 | 17854713 16373670 |
MESH:D001249 |
Asthma |
|
Toluene 2,4-Diisocyanate |
23.32 | 170078 15590891 17015710 11077013 10934080 12762349 18394133 20032816 7684630 12585506 3040596 15855793 19187332 6091946 16210060 11742282 8156442 16792590 12684321 11467998 6091945 15590890 10797510 |
MESH:D001249 |
Asthma |
|
Tretinoin |
23.32 | 16456186 |
MESH:D001250 |
Asthma, Exercise-Induced |
|
Leukotriene B4 |
4.99 | 19667531 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Iron |
10.09 | 15336622 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
10.09 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Acrolein |
14.01 | 17363696 16126721 16037261 |
MESH:D050197 |
Atherosclerosis |
|
Iron |
14.01 | 16632123 16640825 |
MESH:D050197 |
Atherosclerosis |
|
mangiferin |
14.01 | 18450471 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
14.01 | 11922910 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
14.01 | 16873680 17967414 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.28 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Homocysteine |
2.28 | 16297937 20468076 |
MESH:D001321 |
Autistic Disorder |
|
Iron |
2.28 | 17352947 |
MESH:D001321 |
Autistic Disorder |
|
pioglitazone |
2.28 | 17207275 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
3.52 | 19761891 |
MESH:D001424 |
Bacterial Infections |
|
Iron |
4.29 | 16640825 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.53 | 16935849 |
MESH:D001477 |
Bartter Syndrome |
|
Dinoprostone |
4.85 | 15976003 |
MESH:D001768 |
Blister |
|
Mustard Gas |
4.25 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
10.49 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
10.49 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
10.49 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
2.87 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.11 | 15746008 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
4.30 | 16183116 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
3.96 | 14601052 |
MESH:D001862 |
Bone Resorption |
|
Freund's Adjuvant |
7.59 | 16769263 |
MESH:D001862 |
Bone Resorption |
|
mangiferin |
7.59 | 9881647 |
MESH:D001913 |
Bowen's Disease |
|
Sulindac |
4.43 | 11207687 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.41 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
8.02 | 15665606 15845082 15380490 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
8.02 | 16580743 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
3.38 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
18.66 | 17127718 20435547 18840765 15565634 16153821 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
18.66 | 17162533 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
18.66 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
18.66 | 19526202 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
18.66 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
18.66 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
18.66 | 19861407 17261762 18497071 16675129 14630087 12948864 17018787 17289903 |
MESH:D001943 |
Breast Neoplasms |
|
kaempferol |
18.66 | 16756079 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
18.66 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Methylnitrosourea |
18.66 | 11306469 16253758 14633655 |
MESH:D001943 |
Breast Neoplasms |
|
Nitric Oxide |
18.66 | 15631943 |
MESH:D001943 |
Breast Neoplasms |
|
Nordihydroguaiaretic Acid |
18.66 | 18418215 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
18.66 | 16175315 17614352 15562024 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
18.66 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
18.66 | 17049068 15758505 17595753 17261762 17440819 17952589 16837676 15775269 17242785 17893378 15572757 16912660 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
18.66 | 17534123 17651959 16393696 |
MESH:D001943 |
Breast Neoplasms |
|
Sulindac |
18.66 | 16642371 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
18.66 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Toluene 2,4-Diisocyanate |
18.66 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
18.66 | 16443354 16166294 16873071 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Leukotriene B4 |
10.13 | 12654629 12794006 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
10.13 | 17626835 16777450 19059883 18417511 14754758 15516495 18315731 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Toluene 2,4-Diisocyanate |
10.13 | 8156442 15590891 12507178 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
4.25 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
4.05 | 17687719 10378619 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
3.68 | 16813970 |
MESH:D002100 |
Cachexia |
|
Ozone |
3.83 | 16183385 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
4.62 | 16962696 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.55 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
6.99 | 16050911 16011737 15673190 16097048 3786805 16124888 15700767 10355542 16192424 18705752 15721981 16227642 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
6.99 | 16050911 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
5.83 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
5.83 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.23 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
12.43 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
12.43 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
12.43 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
12.43 | 19822196 16569478 18665156 19107877 3084413 20101231 18494052 16540662 19519916 19383236 10737359 19208518 18691550 16698587 20512989 17055752 18971187 19919837 16681979 18978308 20524982 20214788 18210153 16830150 19052882 16935385 19418558 19171122 18785209 17138121 19394651 19539802 18056438 16502159 17761372 17978847 21159647 20727157 3581430 10672840 16779866 16288022 18393292 17173139 17162532 18788625 11831363 16878318 20007298 20514400 16807293 19701751 20432363 16328049 17428255 18506893 20935162 20084675 19335982 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
12.43 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
12.43 | 12508355 19519916 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
12.43 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
12.43 | 1917145 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
3.68 | 16675471 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
2.63 | 16685392 12023789 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.06 | 17234771 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
celecoxib |
3.67 | 16369983 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
9,10-Dimethyl-1,2-benzanthracene |
19.14 | 11376689 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Acetylcysteine |
19.14 | 17015178 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
19.14 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
19.14 | 18337622 17066447 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Isotretinoin |
19.14 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
19.14 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
19.14 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
19.14 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
3.27 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
4.82 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
4.82 | 18670907 18850075 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Iron |
3.39 | 16640825 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Iron |
3.05 | 16604332 |
MESH:D002318 |
Cardiovascular Diseases |
|
clopidogrel |
15.52 | 20180610 |
MESH:D002318 |
Cardiovascular Diseases |
|
kaempferol |
15.52 | 16756079 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
15.52 | 15775269 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
15.52 | 15458977 |
MESH:D002318 |
Cardiovascular Diseases |
|
Tacrolimus |
15.52 | 17703430 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
8.81 | 10977129 |
MESH:D002386 |
Cataract |
|
Methylnitrosourea |
8.81 | 12484553 |
MESH:D002386 |
Cataract |
|
Tretinoin |
8.81 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Acetylcysteine |
17.54 | 18226522 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
17.54 | 21159647 2727394 7505956 17174075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Dinoprostone |
17.54 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
17.54 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
17.54 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitrosourea |
17.54 | 7505956 2727394 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
3.68 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
6.69 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
6.69 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
9.36 | 15861022 17681005 11677210 17333356 16919318 17110522 16105132 |
MESH:D002779 |
Cholestasis |
|
Nitric Oxide |
9.36 | 16919318 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
9.36 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.23 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
7.03 | 12621046 8697196 15340226 16354765 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
7.03 | 9407595 |
MESH:D002972 |
Cleft Palate |
|
Urethane |
7.03 | 12810352 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
3.73 | 15800139 |
MESH:D003092 |
Colitis |
|
resveratrol |
6.69 | 16474422 |
MESH:D003092 |
Colitis |
|
Tretinoin |
6.69 | 17035595 |
MESH:D003093 |
Colitis, Ulcerative |
|
Dinitrochlorobenzene |
3.45 | 17373747 19159591 |
MESH:D003110 |
Colonic Neoplasms |
|
celecoxib |
12.82 | 16004971 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
12.82 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
Iron |
12.82 | 16640825 |
MESH:D003110 |
Colonic Neoplasms |
|
Nordihydroguaiaretic Acid |
12.82 | 15936596 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
12.82 | 15741050 17148506 11134977 19440933 16640504 17191121 19056647 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
12.82 | 16338953 |
MESH:D003110 |
Colonic Neoplasms |
|
Sulindac |
12.82 | 12902858 12458338 |
MESH:D015179 |
Colorectal Neoplasms |
|
Acrolein |
7.92 | 17597105 |
MESH:D015179 |
Colorectal Neoplasms |
|
celecoxib |
7.92 | 11197048 18349538 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
7.92 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
Polychlorinated Biphenyls |
7.92 | 15531428 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
7.92 | 18852136 18095365 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
7.92 | 16550006 |
MESH:D015179 |
Colorectal Neoplasms |
|
Sulindac |
7.92 | 18059344 10666051 11197048 11076880 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.27 | 14669216 17141729 |
MESH:D003324 |
Coronary Artery Disease |
|
Homocysteine |
3.33 | 16379339 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.10 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
8.90 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
8.90 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Isotretinoin |
8.90 | 18769834 9879862 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Reactive Oxygen Species |
8.90 | 15736158 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
8.90 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
8.90 | 9125849 16925845 9142499 17551590 9224671 8800419 9211117 10589399 9664655 14991402 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
8.90 | 19769572 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
3.47 | 14966744 |
MESH:D003457 |
Cryptosporidiosis |
|
mangiferin |
4.93 | 16547730 |
MESH:D003550 |
Cystic Fibrosis |
|
Acetylcysteine |
6.70 | 19747007 |
MESH:D003550 |
Cystic Fibrosis |
|
pioglitazone |
6.70 | 19747007 |
MESH:D003556 |
Cystitis |
|
Acrolein |
4.47 | 12161096 |
MESH:D003704 |
Dementia |
|
Polychlorinated Biphenyls |
3.87 | 16140633 |
MESH:D015140 |
Dementia, Vascular |
|
Nitric Oxide |
5.05 | 17556102 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
3.37 | 17474826 |
MESH:D003872 |
Dermatitis |
|
Benzene |
3.88 | 15902427 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Cilomilast |
12.70 | 12956900 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
12.70 | 12438553 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
diflorasone diacetate |
12.70 | 12956900 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dinitrochlorobenzene |
12.70 | 15491423 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Toluene 2,4-Diisocyanate |
12.70 | 18759878 15491423 12956900 |
MESH:D003876 |
Dermatitis, Atopic |
marker/mechanism |
|
| 18249437 |
MESH:D003876 |
Dermatitis, Atopic |
|
fexofenadine |
5.47 | 17133778 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
5.47 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
Toluene 2,4-Diisocyanate |
3.95 | 17010967 |
MESH:D003920 |
Diabetes Mellitus |
|
Iron |
7.04 | 16604332 16640825 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
7.04 | 17446233 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
mangiferin |
13.61 | 12093613 19028559 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
13.61 | 19496084 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
13.61 | 16873680 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
vanadyl sulfate |
13.61 | 16684804 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Iron |
2.99 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
12.68 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Iron |
12.68 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
mangiferin |
12.68 | 9881663 11315760 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
pioglitazone |
12.68 | 12642470 16023994 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
12.68 | 12642470 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
12.68 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
15.04 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
mangiferin |
15.04 | 19960420 19706694 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
15.04 | 15920148 17308373 17451421 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
15.04 | 16286809 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
3.60 | 17187935 |
MESH:D003930 |
Diabetic Retinopathy |
|
Sulindac |
4.30 | 12861449 17621415 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
5.73 | 7237001 |
MESH:D003967 |
Diarrhea |
|
Dinoprostone |
5.73 | 10446763 11488427 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
7.86 | 15619225 19370779 11529661 19085960 12594235 16109766 19164858 16227642 14550746 16081117 18713872 16393943 19420014 11461765 11739529 17562736 16485898 17522070 11743745 15968718 12540782 12392966 19923254 16781746 2444490 10774834 11287661 11834606 12153990 18071297 17906064 14725611 10915739 14986274 10663392 12705907 19739265 19416960 11421492 12958197 16177239 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetylcysteine |
7.86 | 11287661 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
7.86 | 15998439 2869522 17522070 7440962 16227642 10915739 11566570 16177239 19085960 21278145 9327722 19336974 4309450 15027814 6623471 7179309 15968718 7120509 6884620 3732212 10092053 3786805 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
7.86 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
7.86 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.17 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
5.77 | 12231392 12649298 15033597 19839026 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
5.77 | 11462148 |
MESH:D004381 |
Duodenal Ulcer |
|
Tacrolimus |
4.29 | 17202747 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
2.74 | 18367378 |
MESH:D004417 |
Dyspnea |
|
Albuterol |
4.90 | 20016425 |
MESH:D020821 |
Dystonic Disorders |
|
Nicotine |
5.01 | 17881519 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
3.78 | 9068938 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
3.59 | 12438553 |
MESH:D004487 |
Edema |
|
Carrageenan |
28.01 | 18449507 17259670 18621150 8985016 16100529 10653021 18841975 15860553 12787963 12083418 12798668 |
MESH:D004487 |
Edema |
|
Dexamethasone |
28.01 | 19703484 |
MESH:D004487 |
Edema |
|
Mustard Gas |
28.01 | 9260866 11428647 11402378 11428631 |
MESH:D004487 |
Edema |
|
pirinixic acid |
28.01 | 12083418 |
MESH:D004487 |
Edema |
|
Raloxifene |
28.01 | 15860553 |
MESH:D004487 |
Edema |
|
resveratrol |
28.01 | 8985016 |
MESH:D004487 |
Edema |
|
rosiglitazone |
28.01 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
28.01 | 11000095 12711302 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
28.01 | 15177302 11698051 9599246 16716910 8273558 7812673 8113982 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
8.87 | 15322242 16714409 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
8.87 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
ciglitazone |
19.68 | 16844232 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
19.68 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
19.68 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
19.68 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
19.68 | 17872969 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
5.20 | 18566989 11473722 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
5.20 | 16569247 |
MESH:D004715 |
Endometriosis |
|
celecoxib |
15.30 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
15.30 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Sulindac |
15.30 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
15.30 | 10568697 9294722 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
3.49 | 15328337 17637181 15821434 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
3.96 | 17923197 |
MESH:D004802 |
Eosinophilia |
|
Beclomethasone |
7.12 | 10351924 |
MESH:D004802 |
Eosinophilia |
|
Toluene 2,4-Diisocyanate |
7.12 | 8156442 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
4.25 | 9357497 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.19 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
5.34 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
5.34 | 16481741 15464296 16785472 15173087 17638652 |
MESH:D004938 |
Esophageal Neoplasms |
|
Sulindac |
5.34 | 12235107 |
MESH:D017889 |
Exfoliation Syndrome |
|
Homocysteine |
4.79 | 16504073 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
6.41 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
6.41 | 9664655 16938888 |
MESH:D005128 |
Eye Diseases |
|
Toluene 2,4-Diisocyanate |
4.83 | 18447907 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
33.65 | 12631006 16239168 16045604 61145 15959796 17595544 12795759 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
33.65 | 19004024 17967931 19551842 18296743 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
33.65 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
33.65 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Iron |
33.65 | 16640825 |
MESH:D005234 |
Fatty Liver |
|
mangiferin |
33.65 | 15975614 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
33.65 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
33.65 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
33.65 | 19196556 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.57 | 11858732 |
MESH:D005334 |
Fever |
|
Dinoprostone |
6.95 | 11852909 16997862 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
6.95 | 11852909 9205823 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Sulindac |
4.57 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Sulindac |
4.22 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Carrageenan |
15.27 | 10962813 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
15.27 | 10962813 14633661 |
MESH:D005354 |
Fibrosarcoma |
|
Methylnitrosourea |
15.27 | 11555667 |
MESH:D005355 |
Fibrosis |
|
Albuterol |
23.20 | 15467267 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
23.20 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
23.20 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
23.20 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
23.20 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
23.20 | 17994277 |
MESH:D005621 |
Friedreich Ataxia |
|
Iron |
4.53 | 16640825 16604332 |
MESH:D005739 |
Gas Poisoning |
|
Albuterol |
5.28 | 20016425 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
2.75 | 16983495 |
MESH:D005764 |
Gastroesophageal Reflux |
|
Sulindac |
4.14 | 11910360 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.02 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
4.37 | 16417039 |
MESH:D005901 |
Glaucoma |
|
Homocysteine |
4.43 | 16504073 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
5.06 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
5.06 | 17312396 |
MESH:D005910 |
Glioma |
|
Methylnitrosourea |
4.86 | 9825942 |
MESH:D005910 |
Glioma |
|
Quercetin |
4.86 | 17643826 |
MESH:D005923 |
Glomerulosclerosis, Focal Segmental |
|
pioglitazone |
4.48 | 16687628 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.67 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Tacrolimus |
4.98 | 16376943 |
MESH:D006130 |
Growth Disorders |
|
Tacrolimus |
4.26 | 11041285 |
MESH:D006261 |
Headache |
|
Nitric Oxide |
4.26 | 11284996 11554966 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
5.65 | 15464296 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
5.65 | 16096774 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
3.50 | 19898482 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.23 | 16084493 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
3.64 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
14.92 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Homocysteine |
14.92 | 19638421 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
14.92 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
14.92 | 14991402 9664655 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
14.92 | 16080930 |
MESH:D006331 |
Heart Diseases |
|
mangiferin |
9.00 | 12093613 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
9.00 | 11110106 |
MESH:D006331 |
Heart Diseases |
|
Urethane |
9.00 | 16046796 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
1.91 | 20558911 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
3.80 | 16183116 |
MESH:D006432 |
Hemochromatosis |
|
Iron |
3.77 | 17236123 17053826 16604332 16574947 16640825 17255318 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
8.58 | 16366002 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Shiga Toxin 2 |
8.58 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.50 | 11000095 |
MESH:D006486 |
Hemosiderosis |
|
Iron |
4.29 | 16604332 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
2.74 | 19110552 19900420 |
MESH:D006525 |
Hepatitis, Viral, Human |
|
Iron |
4.54 | 16640825 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Iron |
4.05 | 17182432 |
MESH:D006529 |
Hepatomegaly |
|
Iron |
9.41 | 16890145 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.41 | 18467677 16221962 19772884 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.41 | 16120746 15340226 12621046 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
4.52 | 7520565 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
4.52 | 16863852 16490937 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.10 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
mangiferin |
7.26 | 10715843 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
7.26 | 16876885 |
MESH:D051677 |
Histiocytoma, Malignant Fibrous |
|
1-nitropyrene |
6.28 | 6692400 |
MESH:D015658 |
HIV Infections |
|
Iron |
3.12 | 16597321 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
2.85 | 16200630 16170182 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
7.00 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
7.00 | 14716179 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.12 | 15340226 16959395 16354765 8697196 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
16.61 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Dinoprostone |
16.61 | 16793879 |
MESH:D006930 |
Hyperalgesia |
|
Freund's Adjuvant |
16.61 | 16769263 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
16.61 | 12083418 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
16.61 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
3.62 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
6.47 | 21332399 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
6.47 | 17188708 |
MESH:D006940 |
Hyperemia |
|
Nitric Oxide |
4.70 | 11156591 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
3.67 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
kaempferol |
11.12 | 18262572 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
11.12 | 20558911 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
11.12 | 11834736 18262572 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Homocysteine |
3.92 | 17292331 18234410 17369066 |
MESH:D006946 |
Hyperinsulinism |
|
mangiferin |
4.22 | 9881663 11315760 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
10.73 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
mangiferin |
10.73 | 15975614 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
10.73 | 16873680 |
MESH:D006967 |
Hypersensitivity |
|
Butylated Hydroxytoluene |
14.28 | 17604070 |
MESH:D006967 |
Hypersensitivity |
|
fexofenadine |
14.28 | 17910814 |
MESH:D006967 |
Hypersensitivity |
|
mangiferin |
14.28 | 16536907 |
MESH:D006967 |
Hypersensitivity |
|
Toluene 2,4-Diisocyanate |
14.28 | 10880147 11019492 |
MESH:D006973 |
Hypertension |
|
Benzene |
11.46 | 17940673 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
11.46 | 17042910 |
MESH:D006973 |
Hypertension |
|
Quercetin |
11.46 | 18356687 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
11.46 | 15787275 17577099 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
11.46 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.20 | 15338365 |
MESH:D006976 |
Hypertension, Pulmonary |
|
Nitric Oxide |
3.72 | 15838368 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.49 | 17488730 |
MESH:D007006 |
Hypogonadism |
|
Iron |
3.70 | 16640825 |
MESH:C537153 |
Hypomagnesemia primary |
|
Tacrolimus |
5.24 | 11041285 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
2.92 | 16945680 16569931 |
MESH:D007022 |
Hypotension |
|
Tacrolimus |
4.28 | 11041285 |
MESH:D007037 |
Hypothyroidism |
|
Iron |
4.19 | 16640825 |
MESH:D007154 |
Immune System Diseases |
|
mangiferin |
4.93 | 16076520 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
8.53 | 15869954 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
8.53 | 17600658 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
2.61 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
7.43 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Methylnitrosourea |
7.43 | 7193160 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
7.43 | 16467254 |
MESH:D007249 |
Inflammation |
|
Carrageenan |
51.35 | 7907874 10653021 16100529 18295198 12798668 12428691 12787963 19934399 8985016 |
MESH:D007249 |
Inflammation |
|
Cilomilast |
51.35 | 16956605 17155857 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
51.35 | 11099482 8960868 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
51.35 | 20412841 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
51.35 | 18785209 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
51.35 | 17296493 |
MESH:D007249 |
Inflammation |
|
Freund's Adjuvant |
51.35 | 16793879 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
51.35 | 17963957 9205823 17255318 12878042 17237260 |
MESH:D007249 |
Inflammation |
|
mangiferin |
51.35 | 15222974 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
51.35 | 9260866 11428631 17524151 11428647 8975870 11402378 11428620 16001271 9357497 |
MESH:D007249 |
Inflammation |
|
pioglitazone |
51.35 | 16908763 |
MESH:D007249 |
Inflammation |
|
Progesterone |
51.35 | 15869954 |
MESH:D007249 |
Inflammation |
|
resveratrol |
51.35 | 16366677 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
51.35 | 12083418 |
MESH:D007249 |
Inflammation |
|
Sulindac |
51.35 | 3291741 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
51.35 | 12200463 12878042 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
51.35 | 15177302 8273558 7562506 7812673 11698051 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Leukotriene B4 |
4.00 | 11006272 |
MESH:D007251 |
Influenza, Human |
|
Nordihydroguaiaretic Acid |
25.38 | 18473937 |
MESH:D007251 |
Influenza, Human |
|
pyrrolidine dithiocarbamic acid |
25.38 | 18473937 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
25.38 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
25.38 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
25.38 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
16.18 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
16.18 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
mangiferin |
16.18 | 11315760 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
16.18 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
16.18 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Nitric Oxide |
7.17 | 11574821 11713966 10210152 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
7.17 | 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
|
caffeic acid phenethyl ester |
7.56 | 10783313 |
MESH:D007414 |
Intestinal Neoplasms |
|
Sulindac |
7.56 | 12584176 10223192 10213222 12351151 12628509 12663524 |
MESH:D007417 |
Intestinal Polyps |
|
Sulindac |
4.13 | 12394442 11245490 |
MESH:D002532 |
Intracranial Aneurysm |
|
Reactive Oxygen Species |
4.19 | 19381132 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Iron |
8.76 | 17163184 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
8.76 | 17255318 |
MESH:D007511 |
Ischemia |
|
mangiferin |
4.38 | 16806951 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
7.17 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
7.17 | 15992940 17551590 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.06 | 17086741 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
4.21 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
27.09 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Acrolein |
27.09 | 12488133 |
MESH:D007674 |
Kidney Diseases |
|
caffeic acid phenethyl ester |
27.09 | 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
27.09 | 15190930 19839026 12649298 12231392 18289764 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
27.09 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
mangiferin |
27.09 | 12093613 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
27.09 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Tacrolimus |
27.09 | 11041285 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
27.09 | 12488133 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
2.24 | 15610895 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
8.82 | 16316344 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
8.82 | 11231351 |
MESH:D007859 |
Learning Disorders |
|
mangiferin |
4.07 | 19182383 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
3.64 | 16973256 |
MESH:D007896 |
Leishmaniasis |
|
Nitric Oxide |
3.87 | 17218153 |
MESH:D007938 |
Leukemia |
|
Benzene |
10.47 | 17119257 18335105 15935818 14694614 |
MESH:D007938 |
Leukemia |
|
kaempferol |
10.47 | 17468513 |
MESH:D007938 |
Leukemia |
|
Quercetin |
10.47 | 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
10.47 | 17143497 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
mangiferin |
3.90 | 15498116 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
6.93 | 17506065 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
6.93 | 16932348 19285840 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
3.22 | 19478238 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.22 | 16294345 19850784 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
caffeic acid phenethyl ester |
9.02 | 16766008 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
9.02 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
9.02 | 17339181 15748426 19642359 16331271 17217047 16935935 16140955 12679006 19035177 16766008 16823087 17506722 16891316 19029980 17294898 17301526 17649720 17368321 17712046 19225113 17107899 16788101 9834237 19075265 17361223 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
3.79 | 15821434 |
MESH:D020961 |
Lewy Body Disease |
|
Iron |
4.53 | 16563566 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
3.82 | 16417039 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Methylnitrosourea |
6.10 | 15526292 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
6.10 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
10.89 | 17334410 17157831 16239168 16943688 11408273 21278145 11903743 17174718 16221502 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
10.89 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
10.89 | 20032147 18407596 18665156 19638242 18522880 |
MESH:D008103 |
Liver Cirrhosis |
|
Iron |
10.89 | 16640825 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
Sulindac |
3.58 | 12468960 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
1,3-dimethylthiourea |
22.79 | 11682029 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
22.79 | 12741479 14716833 12632512 14512876 16248980 18481824 12958196 16033810 17631135 15370692 18339082 16097048 15123356 12445421 17766677 18395095 18210741 14620537 15996030 18166357 16192424 12445418 17708605 13678700 12586293 12666154 18187930 18705752 15338365 17640975 17761835 15057751 15362042 18156304 17805973 15876570 16638106 16015684 17869086 18054572 18472332 17900296 17481882 12667390 14748882 18006644 12898905 18429990 12632514 11481614 16136751 18420326 18277467 16116963 15730626 14716496 18472094 17525996 12649538 12609069 12546737 17976157 18251166 18263696 15673190 15893842 18376398 18279442 18395914 17944888 17698563 18205269 18412020 17565644 17714472 18317297 15931870 15052691 17557913 15959796 12389079 15925388 15818738 16011737 17922224 16027843 18418968 17721639 10355542 17823541 20821823 14724832 15650968 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
22.79 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dinoprostone |
22.79 | 15816358 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
22.79 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
22.79 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pioglitazone |
22.79 | 16484506 15052691 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
22.79 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pyrrolidine dithiocarbamic acid |
22.79 | 15078482 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
22.79 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
22.79 | 17347453 15980055 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
22.79 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
22.79 | 16248980 18397230 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
22.79 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
8.71 | 19014921 16610002 19460945 16611625 12969438 19784758 12587719 11587558 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
8.71 | 15830285 16246199 15720792 17285989 16964402 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
8.71 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Dinoprostone |
8.71 | 15816358 |
MESH:D008107 |
Liver Diseases |
|
Sulindac |
8.71 | 16867024 14986274 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Iron |
4.12 | 17207112 16737972 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.27 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
6.71 | 16871587 17185352 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
6.71 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
27.41 | 9643874 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
27.41 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Butylated Hydroxytoluene |
27.41 | 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
27.41 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
27.41 | 21047994 21278145 9163691 19426721 19090486 19690152 20492335 12112319 20434301 20452335 20501860 20137499 18644402 12771043 19850985 19499222 16942905 19294768 19812893 19638242 19073162 20118626 20405173 18977376 19551842 19642983 18754104 21071580 10737359 21167192 15885732 15175105 19427195 20583210 2422723 18648771 19256749 2862719 19833225 19255062 19254457 20101389 18978307 19996281 |
MESH:D008113 |
Liver Neoplasms |
|
Iron |
27.41 | 20302851 16640825 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
27.41 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
27.41 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
27.41 | 19321006 19812893 20405173 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
27.41 | 16984957 |
MESH:D008113 |
Liver Neoplasms |
|
Urethane |
27.41 | 16391232 17559639 17093202 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
9,10-Dimethyl-1,2-benzanthracene |
22.02 | 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
22.02 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
22.02 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
22.02 | 16267830 18775883 19539802 18079962 19009564 18544905 9362446 18253720 19519916 17854601 18308698 19126423 21159647 18093689 17174075 19004024 16842330 2563599 18282651 17942915 18164116 3124819 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
22.02 | 598648 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Polychlorinated Biphenyls |
22.02 | 1423854 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
22.02 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
22.02 | 12151625 |
MESH:D038061 |
Lower Extremity Deformities, Congenital |
|
Methylnitrosourea |
4.57 | 16080182 |
MESH:D008171 |
Lung Diseases |
|
Acetylcysteine |
20.06 | 12815614 |
MESH:D008171 |
Lung Diseases |
|
Acrolein |
20.06 | 11504702 |
MESH:D008171 |
Lung Diseases |
|
Asbestos, Serpentine |
20.06 | 17200189 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
20.06 | 18702808 18161513 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
20.06 | 19066396 8266340 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
20.06 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
3.89 | 14698565 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
14.49 | 21114838 |
MESH:D055370 |
Lung Injury |
|
Nitric Oxide |
14.49 | 11395602 |
MESH:D055370 |
Lung Injury |
|
Ozone |
14.49 | 20417186 |
MESH:D055370 |
Lung Injury |
|
pyrrolidine dithiocarbamic acid |
14.49 | 16129981 |
MESH:D008175 |
Lung Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
47.04 | 11376689 |
MESH:D008175 |
Lung Neoplasms |
|
Asbestos, Serpentine |
47.04 | 11198217 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
47.04 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
47.04 | 6695378 18816296 18520028 20464547 20135361 18569708 17053015 20064080 20869020 |
MESH:D008175 |
Lung Neoplasms |
|
Butylated Hydroxytoluene |
47.04 | 16337739 18597497 11246140 15390079 11696405 19925653 19359593 |
MESH:D008175 |
Lung Neoplasms |
|
ciglitazone |
47.04 | 15899809 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
47.04 | 11798837 17225452 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
47.04 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
47.04 | 20970405 20512841 6695378 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Iron |
47.04 | 16640825 |
MESH:D008175 |
Lung Neoplasms |
|
Isotretinoin |
47.04 | 15899809 |
MESH:D008175 |
Lung Neoplasms |
|
mangiferin |
47.04 | 18520028 18816296 18569708 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
47.04 | 11893704 16271038 10545420 20970405 17909032 7750092 15390079 9230183 21163286 16337739 20512841 6695378 1399818 |
MESH:D008175 |
Lung Neoplasms |
|
Methylnitrosourea |
47.04 | 18062963 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
47.04 | 8781369 3148597 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
47.04 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
47.04 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
Sulindac |
47.04 | 15713900 19359593 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
47.04 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
47.04 | 11807781 |
MESH:D008175 |
Lung Neoplasms |
|
Urethane |
47.04 | 11544531 17255336 6695378 15136453 16391232 11552296 15902970 11992545 7750092 16337739 12466968 11062179 11246140 17195641 10822126 16204055 10779650 11074608 16289808 10530776 15166089 16788158 16926031 16007126 11893704 11307925 11323394 17093202 12957351 11497255 10997738 12765245 14587096 12117781 11807781 |
MESH:D008175 |
Lung Neoplasms |
|
Vehicle Emissions |
47.04 | 9255578 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
47.04 | 11062179 |
MESH:D008223 |
Lymphoma |
|
9,10-Dimethyl-1,2-benzanthracene |
12.28 | 11376689 |
MESH:D008223 |
Lymphoma |
|
Benzene |
12.28 | 17119257 17584886 |
MESH:D008223 |
Lymphoma |
|
Methylnitrosourea |
12.28 | 11418001 16257854 |
MESH:D008223 |
Lymphoma |
|
Nitric Oxide |
12.28 | 16166326 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Methylnitrosourea |
7.72 | 14633661 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
7.72 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.10 | 14749477 |
MESH:D008268 |
Macular Degeneration |
|
Iron |
3.39 | 16640825 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
7.26 | 12562636 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
7.26 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
1-nitropyrene |
33.54 | 6692400 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
9,10-Dimethyl-1,2-benzanthracene |
33.54 | 10697514 1500032 16153821 18840765 11807958 8985016 12844480 16082771 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
33.54 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Butylated Hydroxytoluene |
33.54 | 1500032 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
celecoxib |
33.54 | 12104042 19196722 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
33.54 | 17203775 11408345 16891317 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Methylnitrosourea |
33.54 | 14999141 16619500 16051031 10767621 19196723 15313902 16944150 15688392 11807958 17131329 11751437 12931682 16827153 17020996 15113128 14633655 10838139 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
33.54 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
33.54 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
33.54 | 16827153 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
33.54 | 8985016 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
3.56 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.32 | 17453147 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
13.55 | 12374674 11135225 12393984 16248763 18505091 17023156 16809738 17761969 16432458 18332650 18176117 15577323 12883367 |
MESH:D008545 |
Melanoma |
|
Dinitrochlorobenzene |
13.55 | 12202904 17334785 |
MESH:D008545 |
Melanoma |
|
Isotretinoin |
13.55 | 17237267 |
MESH:D008545 |
Melanoma |
|
Reactive Oxygen Species |
13.55 | 17992120 |
MESH:D008545 |
Melanoma |
|
resveratrol |
13.55 | 17992120 |
MESH:D008545 |
Melanoma |
|
Sulindac |
13.55 | 16642371 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
13.55 | 16752155 |
MESH:D008545 |
Melanoma |
|
Vitamin K 3 |
13.55 | 19082730 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
3.87 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
8.03 | 19513568 |
MESH:D008546 |
Melanoma, Experimental |
|
Acrolein |
8.03 | 10803710 |
MESH:D008569 |
Memory Disorders |
|
mangiferin |
4.07 | 19182383 |
MESH:D008591 |
Meningomyelocele |
|
Homocysteine |
9.46 | 16602021 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
9.46 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
2.79 | 17638057 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.54 | 17112576 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
3.60 | 17261469 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.18 | 10496685 |
MESH:D008881 |
Migraine Disorders |
|
Nitric Oxide |
3.59 | 11701602 |
MESH:D020326 |
Migraine without Aura |
|
Dinoprostone |
8.32 | 11304026 |
MESH:D020326 |
Migraine without Aura |
|
Nitric Oxide |
8.32 | 14659530 11304026 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
4.63 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.45 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
15.28 | 17119195 |
MESH:D009101 |
Multiple Myeloma |
|
celecoxib |
15.28 | 16123214 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
15.28 | 16118317 15744524 15867202 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
15.28 | 16497877 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
15.28 | 17049120 16267019 14749477 16490592 17164350 17935668 |
MESH:D020528 |
Multiple Sclerosis, Chronic Progressive |
|
Iron |
4.74 | 17086897 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
3.96 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
2.62 | 16239165 |
MESH:D009181 |
Mycoses |
|
Iron |
4.54 | 16640825 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
5.50 | 9809623 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
5.50 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Homocysteine |
12.67 | 17412321 |
MESH:D009203 |
Myocardial Infarction |
|
mangiferin |
12.67 | 16584858 16697266 19172585 17052832 16538859 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
12.67 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
12.67 | 19595682 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
12.67 | 16317513 17015251 17125593 17188708 16525036 16456233 |
MESH:D017202 |
Myocardial Ischemia |
|
Iron |
10.98 | 16604332 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
10.98 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
10.98 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
14.27 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Iron |
14.27 | 16604332 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
14.27 | 16411023 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
14.27 | 19207477 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
3.85 | 17322642 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
4.63 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
Acetylcysteine |
7.02 | 14720322 |
MESH:D009362 |
Neoplasm Metastasis |
|
clopidogrel |
7.02 | 11875746 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
7.02 | 9029167 3581430 |
MESH:D009369 |
Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
25.27 | 11544531 |
MESH:D009369 |
Neoplasms |
|
Acrolein |
25.27 | 17329238 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
25.27 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
25.27 | 16773208 |
MESH:D009369 |
Neoplasms |
|
Methylnitrosourea |
25.27 | 15533788 |
MESH:D009369 |
Neoplasms |
|
Nicotine |
25.27 | 16365874 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
25.27 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
25.27 | 15185748 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
25.27 | 16946489 16594593 |
MESH:D009369 |
Neoplasms |
|
Urethane |
25.27 | 15625555 |
MESH:D009374 |
Neoplasms, Experimental |
|
Asbestos, Serpentine |
19.25 | 11704859 |
MESH:D009374 |
Neoplasms, Experimental |
|
Methylnitrosourea |
19.25 | 12696579 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
19.25 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
Toluene 2,4-Diisocyanate |
19.25 | 1670384 |
MESH:D009374 |
Neoplasms, Experimental |
|
Urethane |
19.25 | 15582191 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
celecoxib |
4.51 | 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
7.37 | 17289903 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Nicotine |
7.37 | 16365874 |
MESH:D009393 |
Nephritis |
|
Acrolein |
5.36 | 12653641 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
3.58 | 15464296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Iron |
3.72 | 17178036 |
MESH:D009410 |
Nerve Degeneration |
|
mangiferin |
3.88 | 17433543 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
11.33 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
11.33 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
11.33 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Acetylcysteine |
8.49 | 19446573 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
8.49 | 15643154 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
8.49 | 9142499 |
MESH:D009442 |
Neurilemmoma |
|
Methylnitrosourea |
4.57 | 11555667 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
5.53 | 8761367 |
MESH:D009447 |
Neuroblastoma |
|
Isotretinoin |
5.53 | 17368321 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
27.74 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acrolein |
27.74 | 11342003 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
27.74 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Iron |
27.74 | 16604332 17296847 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
27.74 | 17652729 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Sulindac |
27.74 | 16850258 17266991 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Tacrolimus |
27.74 | 15081597 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
3.79 | 8761367 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
7.87 | 17929310 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
7.87 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.19 | 20387270 |
MESH:D009503 |
Neutropenia |
|
Leukotriene B4 |
7.10 | 8305713 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
7.10 | 7688884 16761898 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
3.31 | 17217161 16723640 20518802 11836018 18457598 21332399 18674790 20132043 19632207 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
3.31 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
6.95 | 17119257 15576619 15727169 17479406 16737584 15935809 15913788 17178637 15612468 |
MESH:D009784 |
Occupational Diseases |
|
Toluene 2,4-Diisocyanate |
6.95 | 6091945 3040596 12585506 18394133 11077013 8156442 6091946 |
MESH:D010003 |
Osteoarthritis |
|
Iron |
3.34 | 16640825 |
MESH:D010005 |
Osteoarthropathy, Secondary Hypertrophic |
|
Dinoprostone |
5.55 | 18500342 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
11.77 | 17882678 |
MESH:D010024 |
Osteoporosis |
|
Iron |
11.77 | 16640825 16648989 |
MESH:D010024 |
Osteoporosis |
|
kaempferol |
11.77 | 16756079 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
11.77 | 17882678 19059307 15775268 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
12.02 | 19495926 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
12.02 | 15579764 17893378 15758505 17823083 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
12.02 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
23.27 | 16891317 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
23.27 | 12562636 |
MESH:D010051 |
Ovarian Neoplasms |
|
CD 437 |
23.27 | 17474084 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
23.27 | 17225452 15464296 19769630 6897625 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
23.27 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
23.27 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
23.27 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
23.27 | 16936753 |
MESH:D010051 |
Ovarian Neoplasms |
|
Urethane |
23.27 | 16391232 |
MESH:D010146 |
Pain |
|
Acetaminophen |
6.95 | 16870215 |
MESH:D010146 |
Pain |
|
Sulindac |
6.95 | 3291741 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.95 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
21.45 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
21.45 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Methylnitrosourea |
21.45 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
21.45 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Reactive Oxygen Species |
21.45 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Sulindac |
21.45 | 11504793 16820089 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
21.45 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
21.45 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
2.83 | 11578682 |
MESH:D010212 |
Papilloma |
|
9,10-Dimethyl-1,2-benzanthracene |
10.83 | 17234724 15173996 16517061 |
MESH:D010212 |
Papilloma |
|
Iron |
10.83 | 12065085 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
10.83 | 18404319 12065085 8330346 18922899 |
MESH:D020447 |
Parasomnias |
|
Iron |
5.09 | 17352947 |
MESH:D010300 |
Parkinson Disease |
|
Acrolein |
11.50 | 17690948 |
MESH:D010300 |
Parkinson Disease |
|
Homocysteine |
11.50 | 16275827 |
MESH:D010300 |
Parkinson Disease |
|
Iron |
11.50 | 16640825 16563566 |
MESH:D010300 |
Parkinson Disease |
|
mangiferin |
11.50 | 17433543 |
MESH:D010300 |
Parkinson Disease |
|
Polychlorinated Biphenyls |
11.50 | 16702228 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.32 | 12520081 |
MESH:D010518 |
Periodontitis |
|
mangiferin |
4.68 | 19026997 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
3.45 | 15464296 |
MESH:D010538 |
Peritonitis |
|
Ozone |
7.79 | 16369182 |
MESH:D010538 |
Peritonitis |
|
Thioglycolates |
7.79 | 19804847 19180231 16751407 15707874 18628355 11985352 19641140 |
MESH:D010787 |
Photosensitivity Disorders |
|
Acrolein |
4.81 | 11550810 |
MESH:D010900 |
Pituitary Diseases |
|
Iron |
4.74 | 16604332 |
MESH:D010911 |
Pituitary Neoplasms |
|
Urethane |
4.52 | 16391232 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Serpentine |
4.80 | 10923243 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
4.42 | 17638057 |
MESH:D010998 |
Pleurisy |
|
Carrageenan |
5.82 | 19934399 |
MESH:D011014 |
Pneumonia |
|
Butylated Hydroxytoluene |
13.45 | 11893704 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
13.45 | 12224865 11605937 |
MESH:D011014 |
Pneumonia |
|
Ozone |
13.45 | 18007984 18381685 18929643 |
MESH:D011015 |
Pneumonia, Aspiration |
|
Nitric Oxide |
4.43 | 18573544 |
MESH:D011041 |
Poisoning |
|
Iron |
6.21 | 16604332 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
6.21 | 15727166 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Iron |
8.13 | 16640825 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
8.13 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
6.59 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
6.59 | 19056647 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
2.95 | 21297632 |
MESH:D011225 |
Pre-Eclampsia |
|
Iron |
3.68 | 16640825 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Isotretinoin |
15.94 | 18769834 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
15.94 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
15.94 | 11222880 11896295 11399792 11118676 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
15.94 | 18220299 18042343 19015723 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.02 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.05 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.86 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
celecoxib |
3.86 | 15570007 17908994 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.86 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Hyaluronic Acid |
3.86 | 16864594 |
MESH:D011471 |
Prostatic Neoplasms |
|
Methylnitrosourea |
3.86 | 12376480 15682402 |
MESH:D011471 |
Prostatic Neoplasms |
|
Nordihydroguaiaretic Acid |
3.86 | 18491370 |
MESH:D011471 |
Prostatic Neoplasms |
|
Polychlorinated Biphenyls |
3.86 | 15721890 |
MESH:D011471 |
Prostatic Neoplasms |
|
pyrrolidine dithiocarbamic acid |
3.86 | 16139439 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
3.86 | 17292933 14715546 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
3.86 | 16536755 16220300 15731164 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
3.86 | 17675339 17718901 15767336 16731767 17636462 17804756 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
3.86 | 15084515 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.02 | 18629315 |
MESH:D011507 |
Proteinuria |
|
pioglitazone |
6.88 | 16687628 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
6.88 | 16636307 |
MESH:D011528 |
Protozoan Infections |
|
Iron |
5.09 | 16640825 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
11.15 | 15861022 16919318 |
MESH:D011537 |
Pruritus |
|
fexofenadine |
11.15 | 17133778 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
11.15 | 18058305 |
MESH:D011565 |
Psoriasis |
|
Leukotriene B4 |
3.92 | 11006272 |
MESH:D011596 |
Psychomotor Disorders |
|
Isotretinoin |
5.01 | 18769834 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
3.88 | 16723453 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
Toluene 2,4-Diisocyanate |
4.70 | 14606601 |
MESH:D011658 |
Pulmonary Fibrosis |
marker/mechanism |
|
| 17620002 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Serpentine |
4.67 | 18569384 15511213 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
4.67 | 10334151 17894541 17720292 17266442 17620002 |
MESH:D011693 |
Purpura |
|
Raloxifene |
4.63 | 15770314 |
MESH:D011833 |
Radiation Injuries, Experimental |
|
mangiferin |
5.48 | 15830843 |
MESH:D051437 |
Renal Insufficiency |
|
Acrolein |
7.72 | 12732208 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
7.72 | 15464296 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
4.65 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
4.74 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
4.74 | 16317513 16314181 15827377 17520802 17058453 |
MESH:D012120 |
Respiration Disorders |
|
Cilomilast |
5.74 | 17155857 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Acetylcysteine |
10.60 | 12210543 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
10.60 | 18379247 11700416 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
pyrrolidine dithiocarbamic acid |
10.60 | 16129981 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
6.39 | 10835634 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Toluene 2,4-Diisocyanate |
6.39 | 7692837 20219652 16940033 |
MESH:D012135 |
Respiratory Sounds |
|
Vehicle Emissions |
4.34 | 18950799 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
2.96 | 18990726 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Toluene 2,4-Diisocyanate |
4.20 | 18447907 |
MESH:D012148 |
Restless Legs Syndrome |
|
Iron |
3.82 | 16930377 |
MESH:D012162 |
Retinal Degeneration |
|
Methylnitrosourea |
3.69 | 18155124 18172121 |
MESH:D012170 |
Retinal Vein Occlusion |
|
clopidogrel |
5.23 | 19371211 |
MESH:D012175 |
Retinoblastoma |
|
Methylnitrosourea |
4.57 | 11555667 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.25 | 16283617 16116481 |
MESH:D012220 |
Rhinitis |
|
Beclomethasone |
7.13 | 10351924 |
MESH:D012220 |
Rhinitis |
|
Toluene 2,4-Diisocyanate |
7.13 | 19050374 |
MESH:D012221 |
Rhinitis, Allergic, Perennial |
|
Toluene 2,4-Diisocyanate |
4.36 | 12617775 15015336 |
MESH:D006255 |
Rhinitis, Allergic, Seasonal |
|
Toluene 2,4-Diisocyanate |
4.59 | 19075512 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.43 | 18045962 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
3.56 | 14601052 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
4.62 | 16862918 |
MESH:D012555 |
Schistosomiasis mansoni |
|
Nitric Oxide |
4.58 | 9673227 |
MESH:D012559 |
Schizophrenia |
|
Homocysteine |
2.95 | 16641680 |
MESH:D012640 |
Seizures |
|
Nicotine |
3.19 | 17873105 |
MESH:D012772 |
Shock, Septic |
|
mangiferin |
4.33 | 15177305 |
MESH:D012852 |
Sinusitis |
|
Beclomethasone |
5.51 | 7327846 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
3.86 | 16961503 15451306 12880345 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
3.86 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
26.40 | 8985016 15173996 11376689 16517061 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
26.40 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Iron |
26.40 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
26.40 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
26.40 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
26.40 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
26.40 | 18404319 12065085 8330346 11807781 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
26.40 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
Urethane |
26.40 | 11807781 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
4.42 | 15464296 |
MESH:D012912 |
Sneezing |
|
Toluene 2,4-Diisocyanate |
4.59 | 19075512 19050374 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.02 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
3.37 | 16503802 15862959 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
3.42 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
7.73 | 12562636 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
7.73 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
celecoxib |
7.73 | 15609394 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
7.73 | 17522103 18396642 15958060 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
7.73 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Methylnitrosourea |
7.73 | 18593901 15930296 16257854 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
7.73 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Acetylcysteine |
14.04 | 17918041 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
14.04 | 15138204 |
MESH:D013276 |
Stomach Ulcer |
|
fucoidan |
14.04 | 18209962 15138204 |
MESH:D013276 |
Stomach Ulcer |
|
mangiferin |
14.04 | 17918041 |
MESH:D013276 |
Stomach Ulcer |
|
Nitric Oxide |
14.04 | 15138204 |
MESH:D020521 |
Stroke |
|
Acrolein |
10.17 | 16269634 |
MESH:D020521 |
Stroke |
|
Raloxifene |
10.17 | 16837676 |
MESH:D020521 |
Stroke |
|
Vitamin E |
10.17 | 16517955 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
3.66 | 16321402 |
MESH:D013398 |
Sudden Infant Death |
|
Iron |
4.54 | 16640825 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
3.78 | 15464296 17225452 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.36 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
2.77 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.37 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
9.21 | 10850423 |
MESH:D013953 |
Thymus Neoplasms |
|
Methylnitrosourea |
9.21 | 11418001 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
2.98 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
7.86 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Methylnitrosourea |
7.86 | 3078959 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.86 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
10.64 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
10.64 | 19048282 |
OMIM:188890 |
TOBACCO ADDICTION, SUSCEPTIBILITY TO |
|
Nicotine |
4.01 | 16720336 11259349 16785264 |
MESH:D014029 |
Tobacco Use Disorder |
|
Nicotine |
4.56 | 15735609 18305452 18041664 17979512 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
7.21 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
7.21 | 16051514 |
MESH:D014235 |
Trichinellosis |
|
mangiferin |
5.13 | 14669257 |
MESH:D014376 |
Tuberculosis |
|
Iron |
6.02 | 16597321 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
6.02 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2-Naphthylamine |
16.86 | 11144890 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
16.86 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
CD 437 |
16.86 | 16720286 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
16.86 | 12973940 15464296 17225452 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
16.86 | 16720314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
16.86 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Vehicle Emissions |
16.86 | 11144890 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.14 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
11.27 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
11.27 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
11.27 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
20.93 | 12562636 |
MESH:D014594 |
Uterine Neoplasms |
|
celecoxib |
20.93 | 18645019 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
20.93 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
20.93 | 17044934 |
MESH:D014594 |
Uterine Neoplasms |
|
Sulindac |
20.93 | 18645019 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
3.68 | 16752155 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
3.89 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
3.72 | 15577323 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.67 | 12125929 |
MESH:D019043 |
Vascular Neoplasms |
|
Urethane |
4.98 | 10620525 |
MESH:D020301 |
Vasospasm, Intracranial |
|
Nitric Oxide Donors |
5.24 | 19057314 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
4.28 | 16837676 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
2.71 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
3.42 | 17488730 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.19 | 16761959 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
3.80 | 11897121 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
4.63 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.32 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
2.95 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.17 | 16287080 |